-
出版商:
Springer
-
出版日期:
2024-05-22
-
售價:
$2,680
-
貴賓價:
9.5 折
$2,546
-
語言:
英文
-
頁數:
149
-
裝訂:
Quality Paper - also called trade paper
-
ISBN:
9819921376
-
ISBN-13:
9789819921379
-
相關分類:
物聯網 IoT
商品描述
This book covers an extensive range of issues raised by biotechnological advancements from a regulatory perspective. Written in a clear and readable style, its main objective is to give readers an idea of the relationship between biotechnology and law. Biotechnology advancements and their ethical, moral, economic, and social implications in different fields and the consequential normative demands on the law are crucial to this book. The chapters cover a multitude of themes and some of the most important legal issues arising in relation to biotechnology, including the historical development of a legal framework sufficient to protect public safety, the current biotechnology regulatory system, and the rules directing the primary agencies that regulate the products of biotechnology, namely the US Food and Drug Administration, the US Department of Agriculture, and the US Environmental Protection Agency, patents and IP rights in biotechnology, the regulation of human genome editingand its impact on health research, law and emerging genome editing technologies from recombinant DNA to CRISPR/Cas9, the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and legal issues arising from the use of genetic engineered plants and animals.
Presenting arguments that have been drawn from careful examination of various international documents and decisions made by legal institutions and judicial bodies, this book would be a valuable read for practitioners as well as academics of biotechnology law.
商品描述(中文翻譯)
這本書從監管的角度涵蓋了生物技術進展所引發的廣泛問題。以清晰易讀的風格撰寫,其主要目標是讓讀者了解生物技術與法律之間的關係。生物技術的進展及其在不同領域中的道德、經濟和社會影響,以及對法律的規範性要求,對本書至關重要。各章節涵蓋了眾多主題,以及與生物技術相關的一些最重要的法律問題,包括建立足以保護公共安全的法律框架的歷史發展,現行的生物技術監管體系,以及指導生物技術產品主要監管機構(即美國食品藥品監督管理局、美國農業部和美國環境保護局)的規則,生物技術中的專利和知識產權,對人類基因編輯的監管及其對健康研究的影響,從重組DNA到CRISPR/Cas9的法律和新興基因編輯技術,制定保護人體財產權並允許有效利用人體組織、器官、DNA和細胞系列進行醫學研究的法律原則的發展,以及使用基因工程植物和動物所引發的法律問題。
本書提出的論點是通過對各種國際文件和法律機構及司法機構的決策的仔細研究而得出的,對生物技術法律的從業人員和學者來說,這本書將是一本有價值的閱讀材料。
作者簡介
Alessandro Stasi is an Assistant Professor in Law at Mahidol University International College (MUIC), Thailand. He has authored several books and academic articles in leading international journals. Prior to joining Mahidol University International College, he held academic posts at Ramkhamhaeng University and King Mongkut's Institute of Technology Ladkrabang. Alessandro Stasi also provides advice to private clients, international organizations, and non-governmental organizations. He read Law at the University of Naples Federico II, Italy, and subsequently completed an LLM with Merit and two PhD degrees at the University of Nice Sophia-Antipolis in France.
作者簡介(中文翻譯)
Alessandro Stasi是泰國馬希達府國際學院(MUIC)的法學助理教授。他在領先的國際期刊上撰寫了幾本書籍和學術文章。在加入馬希達府國際學院之前,他曾在蘭甘大學和國王蒙古特技術學院擔任學術職位。Alessandro Stasi還為私人客戶、國際組織和非政府組織提供諮詢服務。他在意大利那不勒斯大學攻讀法學學位,並在法國尼斯索菲亞大學獲得了優異的碩士學位和兩個博士學位。